PortfoliosLab logoPortfoliosLab logo
LOGSX vs. SHPAX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

LOGSX vs. SHPAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Live Oak Health Sciences Fund (LOGSX) and Saratoga Health & Biotechnology Fund (SHPAX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LOGSX achieves a 0.81% return, which is significantly higher than SHPAX's 0.05% return. Both investments have delivered pretty close results over the past 10 years, with LOGSX having a 7.08% annualized return and SHPAX not far behind at 6.73%.


LOGSX

1D
0.81%
1M
-0.63%
YTD
0.81%
6M
-0.39%
1Y
17.95%
3Y*
8.66%
5Y*
5.93%
10Y*
7.08%

SHPAX

1D
0.76%
1M
-0.84%
YTD
0.05%
6M
-1.21%
1Y
16.81%
3Y*
7.07%
5Y*
4.68%
10Y*
6.73%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LOGSX vs. SHPAX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LOGSX
Live Oak Health Sciences Fund
0.81%19.63%0.16%1.21%3.71%17.59%6.01%18.98%-3.84%13.42%
SHPAX
Saratoga Health & Biotechnology Fund
0.05%17.43%0.26%-0.36%1.93%16.71%3.52%27.67%-5.30%11.78%

Correlation

The correlation between LOGSX and SHPAX is 1.00 - these two move nearly in lockstep. At this level, holding both provides almost no diversification benefit. If you already own one, adding the other does little to reduce portfolio risk.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

1.00

Correlation (3Y)
Calculated over the trailing 3-year period

0.99

Correlation (5Y)
Calculated over the trailing 5-year period

0.99

Correlation (10Y)
Calculated over the trailing 10-year period

0.99

Correlation (All Time)
Calculated using the full available price history since Jun 29, 2001

0.95

The correlation between LOGSX and SHPAX has been stable across timeframes, ranging from 0.95 to 1.00 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LOGSX vs. SHPAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LOGSX
LOGSX Risk / Return Rank: 2626
Overall Rank
LOGSX Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
LOGSX Sortino Ratio Rank: 2323
Sortino Ratio Rank
LOGSX Omega Ratio Rank: 2020
Omega Ratio Rank
LOGSX Calmar Ratio Rank: 3838
Calmar Ratio Rank
LOGSX Martin Ratio Rank: 2424
Martin Ratio Rank

SHPAX
SHPAX Risk / Return Rank: 2121
Overall Rank
SHPAX Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
SHPAX Sortino Ratio Rank: 2020
Sortino Ratio Rank
SHPAX Omega Ratio Rank: 1818
Omega Ratio Rank
SHPAX Calmar Ratio Rank: 2727
Calmar Ratio Rank
SHPAX Martin Ratio Rank: 1919
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LOGSX vs. SHPAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Live Oak Health Sciences Fund (LOGSX) and Saratoga Health & Biotechnology Fund (SHPAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LOGSXSHPAXDifference
Sharpe ratioReturn per unit of total volatility

+0.08

Sortino ratioReturn per unit of downside risk

+0.12

Omega ratioGain probability vs. loss probability

1.22

1.20

+0.01

Calmar ratioReturn relative to maximum drawdown

2.22

1.82

+0.41

Martin ratioReturn relative to average drawdown

5.46

4.51

+0.95

LOGSX vs. SHPAX - Sharpe Ratio Comparison

The current LOGSX Sharpe Ratio is 1.24, which is comparable to the SHPAX Sharpe Ratio of 1.16. The chart below compares the historical Sharpe Ratios of LOGSX and SHPAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LOGSX vs. SHPAX - Drawdown Comparison

The maximum LOGSX drawdown since its inception was -45.85%, smaller than the maximum SHPAX drawdown of -69.50%. Use the drawdown chart below to compare losses from any high point for LOGSX and SHPAX.


Loading charts...

Drawdown Indicators


LOGSXSHPAXDifference

Max Drawdown

Largest peak-to-trough decline

-45.85%

-69.50%

+23.65%

Max Drawdown (1Y)

Largest decline over 1 year

-8.13%

-9.33%

+1.20%

Max Drawdown (3Y)

Largest decline over 3 years

-14.33%

-16.32%

+1.99%

Max Drawdown (5Y)

Largest decline over 5 years

-15.03%

-16.32%

+1.29%

Max Drawdown (10Y)

Largest decline over 10 years

-27.28%

-28.05%

+0.77%

Current Drawdown

Current decline from peak

-4.47%

-5.88%

+1.41%

Average Drawdown

Average peak-to-trough decline

-7.60%

-27.88%

+20.28%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.31%

3.75%

-0.44%

Volatility

LOGSX vs. SHPAX - Volatility Comparison

Live Oak Health Sciences Fund (LOGSX) and Saratoga Health & Biotechnology Fund (SHPAX) have volatilities of 5.20% and 5.14%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LOGSXSHPAXDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.20%

5.14%

+0.06%

Volatility (6M)

Calculated over the trailing 6-month period

10.42%

10.44%

-0.02%

Volatility (1Y)

Calculated over the trailing 1-year period

14.57%

14.64%

-0.07%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

14.26%

14.34%

-0.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

16.17%

16.62%

-0.45%

LOGSX vs. SHPAX - Expense Ratio Comparison

LOGSX has a 1.02% expense ratio, which is lower than SHPAX's 2.90% expense ratio.


Dividends

LOGSX vs. SHPAX - Dividend Comparison

LOGSX's dividend yield for the trailing twelve months is around 2.06%, less than SHPAX's 3.66% yield.


PositionTTM20252024202320222021202020192018201720162015
LOGSX
Live Oak Health Sciences Fund
2.06%2.07%2.64%6.28%0.55%7.02%7.04%0.85%15.20%6.45%2.10%15.52%
SHPAX
Saratoga Health & Biotechnology Fund
3.66%3.66%1.35%5.38%6.34%3.76%13.82%13.24%22.00%17.98%12.52%10.70%

Frequently Asked Questions


With a correlation of 1.00, LOGSX and SHPAX move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.

LOGSX has higher volatility (5.20%) compared to SHPAX (5.14%). In terms of maximum drawdown, LOGSX dropped -45.85% vs SHPAX's -69.50%.

LOGSX currently has the higher Sharpe Ratio (1.24 vs 1.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LOGSX and SHPAX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer